최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology, v.9 no.1, 2005년, pp.1 - 8
Lubov, Timchenko (Department of Medicine, Section of Cardiovascular Sciences, Baylor College of Medicine)
Myotonic Dystrophies type 1 and 2 (DM1/2) are neuromuscular disorders which belong to a group of genetic diseases caused by unstable CTG triplet repeat (DM1) and CCTG tetranucleotide repeat (DM2) expansions. In DM1, CTG repeats are located within the 3' untranslated region of myotonin protein kinase...
Amack JD, Mahadevan MS. The myotonic dystrophy expanded CUG repeat track is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum Mol Genet 10: 1879-1887, 2001
Aslanidis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, Tsilfidis C, Clen C, Alleman J, Wormskamp NG, Vooijs M, Buxton J, Johnson K, Sweets HJM, Lennon GG, Carrano AV, Korneluk RG, Wieringa B, deJong PJ. Cloning of essential myotonic dystrophy region and mapping of the putative defect. Nature 355: 548-551, 1992
Baldwin BR, Timchenko NA, Zahnow CA. Epidermal growth factor receptor stimulation activates the RNA binding protein CUGBP1 and increases expression of C/EBPbeta-LIP in mammary epithelial cells. Mol Cell Biol 24: 3682-3691, 2004
Brook JD, McCurrah ME, Harley HG, Buckler AJ, Church D, Aburatan H, Hunter K, Stanton VP, Thirion J-P, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE. Molecular basis of myotonic dystrophy: expansion of atrinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 68: 799-808, 1992
Calkhoven CF, Bouwman PRJ, Snippe L, Geert AB. Translation start site multiplicity of the CCAAT/enhancer binding protein $\alpha$ mRNA is dictated by a small 5' open reading frame. Nucl Acids Res 22: 5540-5547, 1994
Calkhoven CF, Muller C, Leutz A. Translational control of C/EBP $\alpha$ and C/EBP $\beta$ isoform expression. Genes & Dev 14: 1920-1932, 2000
Charlet-B N, Savcur RS, Singh G, Philips AV, Grice EA, Cooper TA. Loss of the Muscle specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10: 45-43, 2002
Cooper TA, Ordahl CP. A single troponin T gene regulated by different programs in cardiac and skeletal muscle development. Science 226: 979-982, 1984
Cooper TA, Ordahl CP. A single cardiac troponin T gene generates embryonic and adult isoforms via developmentally regulated alternative splicing. J Biol Chem 260: 11140-11148, 1985
Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LPW. Myotonic dystrophy type 2. Neurol 60: 657- 664, 2003
Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67: 569-579, 1991
Ebralidze A, Wang Y, Petkova V, Ebralidze K, Junghans RP. RNA leaching of transcription factors disrupts transcription in myotonic dystrophy. Science 303: 383-387, 2004
Fardaei M, Larkin K, Brook JD, Hamshere MG. In vivo co localization of MNBL protein with DMPK expanded- repeat transcripts. Nucl Acids Res 29: 2766-2771, 2001
Finsterer J. Myotonic Dystrophy type 2. Eur J Neurol 9: 441-447, 2002
Fu YH, Friedman DL, Richards S, Pearlman JA, Gibbs RA, Pizzuti A, Ashizawa T, Perryman MB, Scarlato G, Fenwick RG, Caskey CT. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260: 235-238, 1993
Fu YH, Pizzuti RG, Fenwick JK Jr, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, DeJong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255: 1256-1258, 1992
Harper PS. Myotonic Dystrophy. WB Saunders, London, UK, 2001
Iakova P, Wang G-L, Timchenko, L, Michalak M, Pereira-Smith OM, Smith JR, Timchenko NA. Competition of CUGBP1 and calreticulin for the regulation of p21 translation determined cell fate. EMBO J 23: 407-417, 2004
Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thrornton CA, Esson D, Timmers AM, Hauswirth WW, Swanson MS. A muscleblind knockout model for Myotonic dystrophy. Science 302: 1978-1980, 2003
Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LPW. Myotonic dystrophy type 2 caused by a CCTG expansion in intron of ZNF9. Science 293: 864-867, 2001
Luedde T, Duderstadt M, Streetz KL, Tacke F, Kubicka S, Manns MP, Trautwein C. C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver. Hepatology 40: 356-365, 2004
Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barcelo J, O'Hoy K, Leblond S, Earle-MacDonald J, De Jong PJ, Wieringa B, Korneluk RG. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 255: 1253-1256, 1992
Mankodi A, Urbinati CR, Yuan QP, Moxley RT, Sansone V, Krym M, Henderson D, Schalling M, Swanson MS, Thornton CA. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 10: 2165-2170, 2001
Mankodi M, Logigian E, Callahan L, McClain C, White R, Henderson D, Krym M, Thornton CA. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289: 1769-1772, 2000
Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS. Recruitment of human muscleblind proteins to (CUG)n expansions associated with myotonic dystrophy. EMBO J 19: 4439-4448, 2000
Molkentin JD, Black BL, Martin JF, Olson EN. Cooperative activation of muscle gene expression by MEF2 and myogenic transcription factors. Cell 83: 1125-11330, 1995
Otten AD, Tapscott SJ. Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure. Proc Natl Acad Sci (USA) 92: 5465-5469, 1995
Philips AV, Timchenko LT, Cooper TA. Disruption of splicing of regulated by CUG binding protein in myotonic dystrophy. Science 280: 737-741, 1998
Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273: 29279-29282, 1998
Ranum LP, Day JW. Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet 74: 793-804, 2004
Savcur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LPW, Day JW. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 74: 1309-1313, 2004
Savcur RS, Philips AV, Cooper TA. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29: 40-47, 2001
Seznec H, Agbulut O, Sergeant N, Savouret C, Ghestem A, Tabti N, Willer JC, Ourth L, Duros Brisson E, Fouquet C, Butler-Browne G, Delacourte A, Junien C, Gourdon G. Mice transgenic for the human myotonic dystrophy with expanded CTG repeats display muscular and brain abnormalities. Hum Mol Genet 10: 2717-2726, 2001
Taneja KL, McCurrach M, Schalling M, Housman D, Singer RH. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 128: 995-1002, 1995
Timchenko LT. Myotonic dystrophy: the role of RNA CUG repeats. Am J Hum Genet 64: 360-364, 1999
Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS. Identification of a (CUG) ntriplet repeat binding protein and its expression in myotonic dystrophy. Nucl Acids Res 24: 4407-44116, 1996
Timchenko LT, Timchenko NA, Caskey CT, Roberts R. Novel proteins with binding specificity to DNA CTG and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet 5: 115-121, 1996
Timchenko NA, Cai Z-J, Welm AL, Reddy S, Ashizawa T, Timchenko LT. RNA CUG repeats sequester and alter protein levels and activity of CUGBP1. J Biol Chem 276: 7820-7826, 2001
Timchenko NA, Iakova P, Cai Z-J, Smith JR, Timchenko LT. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol 21: 6927-6938, 2001
Timchenko NA, Patel R, Iakova P, Cai Z-J, Quan L, Timchenko LT. Overexpression of CUG triplet repeat- binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem 279: 13129-13139, 2004
Timchenko NA, Welm AL, Lu X, Timchenko LT. CUG repeat binding protein (CUGBP1) interacts with the 5' region of C/ EBPbeta mRNA and regulates translation of C/EBPbeta isoforms. Nucl Acids Res 27: 4517-4525, 1999
Udd B, Krahe R, Wallgren-Petterson C, Falck B, Kalimo H. Proximal myotonic dystrophy - a family of with autosomal dominant muscular dystrophy, cataracts, hearing loss and hypogonadism:heterogeneity of proximal myotonic syndromes? Neuromuscul Disord 7: 217-228, 1997
Welm AL, Mackey SL, Timchenko LT, Darlington GJ, Timchenko NA. Translational Induction of Liver-enriched Transcriptional Inhibitory Protein during Acute Phase Response Leads to Repression of CCAAT/Enhancer Binding Protein $\alpha$ mRNA. J Biol Chem 275: 27406-27413, 2000
Wu H, Olson EN. Activation of the MEF2 transcription factor in skeletal muscles from myotonic mice. J Clin Invest 109: 1327-1333, 2002
Zhang P, Wong C, Liu D, Finegold M, Harper WJ, Elledge SJ. P21 (CIP1) and p57 (KIP2) control muscle differentiation at the myogenin step. Genes Dev 13: 213-224, 1999
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.